IBEX Ltd
For the period ended Mar 31, 2024. Filed May 9, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2024 · Filed May 9, 2024
IBEX$52.23+3.9%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Stockholders' Equity (unaudited)
Consolidated Statements of Stockholders’ Equity
(in thousands)
| Common shares · TreasuryStock · AdditionalPaid-inCapital · Accumulated OtherComprehensiveIncome / (Loss) · AccumulatedDeficit · TotalStockholders'Equity | |||||||
|---|---|---|---|---|---|---|---|
| Shares · Amount · Amount | |||||||
| Balance, December 31, 2022 | 18,298 | $2 | $(3,682) | $201,102 | $(5,132) | $(60,567) | $131,723 |
| Net income | — | — | — | — | — | 11,279 | 11,279 |
| Foreign currency translation adjustment | — | — | — | — | (1,039) | — | (1,039) |
| Changes in fair value of cash flow hedges | — | — | — | — | 216 | — | 216 |
| Provision for common stock warrants | — | — | — | 260 | — | — | 260 |
| Issuance of common shares | 34 | — | — | 618 | — | — | 618 |
| Forfeiture of restricted common shares | (68) | — | — | — | — | — | — |
| Share-based compensation expense | — | — | — | 1,311 | — | — | 1,311 |
| Balance, March 31, 2023 | 18,264 | $2 | $(3,682) | $203,291 | $(5,955) | $(49,288) | $144,368 |
| Common shares · TreasuryStock · AdditionalPaid-inCapital · Accumulated OtherComprehensiveIncome / (Loss) · AccumulatedDeficit · TotalStockholders'Equity | |||||||
|---|---|---|---|---|---|---|---|
| Shares · Amount · Amount | |||||||
| Balance, December 31, 2023 | 17,681 | $2 | $(14,116) | $207,638 | $(6,133) | $(31,278) | $156,113 |
| Net income | — | — | — | — | — | 10,310 | 10,310 |
| Foreign currency translation adjustment | — | — | — | — | (288) | — | (288) |
| Changes in fair value of cash flow hedges | — | — | — | — | (131) | — | (131) |
| Purchase of treasury shares | (502) | — | (8,117) | — | — | — | (8,117) |
| Provision for common stock warrants | — | — | — | 299 | — | — | 299 |
| Issuance of common shares | 35 | — | — | 351 | — | — | 351 |
| Share-based compensation expense | — | — | — | 774 | — | — | 774 |
| Balance, March 31, 2024 | 17,214 | $2 | $(22,233) | $209,062 | $(6,552) | $(20,968) | $159,311 |
| Common shares · TreasuryStock · AdditionalPaid-inCapital · Accumulated OtherComprehensiveIncome / (Loss) · AccumulatedDeficit · TotalStockholders'Equity | |||||||
|---|---|---|---|---|---|---|---|
| Shares · Amount · Amount | |||||||
| Balance, June 30, 2022 | 18,247 | $2 | $(3,406) | $197,785 | $(4,562) | $(76,360) | $113,459 |
| Net income | — | — | — | — | — | 27,072 | 27,072 |
| Foreign currency translation adjustment | — | — | — | — | (2,162) | — | (2,162) |
| Changes in fair value of cash flow hedges | — | — | — | — | 769 | — | 769 |
| Purchase of treasury shares | (18) | — | (276) | — | — | — | (276) |
| Provision for common stock warrants | — | — | — | 856 | — | — | 856 |
| Issuance of common shares | 103 | — | — | 1,827 | — | — | 1,827 |
| Forfeiture of restricted common shares | (68) | — | — | — | — | — | — |
| Share-based compensation expense | — | — | — | 2,823 | — | — | 2,823 |
| Balance, March 31, 2023 | 18,264 | $2 | $(3,682) | $203,291 | $(5,955) | $(49,288) | $144,368 |
| Common shares · TreasuryStock · AdditionalPaid-inCapital · Accumulated OtherComprehensiveIncome / (Loss) · AccumulatedDeficit · TotalStockholders'Equity | |||||||
|---|---|---|---|---|---|---|---|
| Shares · Amount · Amount | |||||||
| Balance, June 30, 2023 | 18,280 | $2 | $(3,682) | $204,734 | $(6,312) | $(44,778) | $149,964 |
| Net income | — | — | — | — | — | 23,810 | 23,810 |
| Foreign currency translation adjustment | — | — | — | — | (310) | — | (310) |
| Changes in fair value of cash flow hedges | — | — | — | — | 70 | — | 70 |
| Purchase of treasury shares | (1,125) | — | (18,551) | — | — | — | (18,551) |
| Provision for common stock warrants | — | — | — | 893 | — | — | 893 |
| Issuance of common shares | 59 | — | — | 362 | — | — | 362 |
| Share-based compensation expense | — | — | — | 3,073 | — | — | 3,073 |
| Balance, March 31, 2024 | 17,214 | $2 | $(22,233) | $209,062 | $(6,552) | $(20,968) | $159,311 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.